Silvercrest Asset Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-176,125
| Closed | -$2.3M | – | 824 |
|
|
2022
Q3 | $2.3M | Sell |
176,125
-4,797
| -3% | -$62.8K | 0.02% | 429 |
|
|
2022
Q2 | $2.32M | Sell |
180,922
-8,083
| -4% | -$104K | 0.02% | 447 |
|
|
2022
Q1 | $2.88M | Buy |
189,005
+1,762
| +0.9% | +$26.9K | 0.02% | 448 |
|
|
2021
Q4 | $3.32M | Hold |
187,243
| – | – | 0.02% | 426 |
|
|
2021
Q3 | $3.94M | Buy |
187,243
+70,981
| +61% | +$1.49M | 0.03% | 409 |
|
|
2021
Q2 | $2.29M | Buy |
116,262
+61,920
| +114% | +$1.22M | 0.02% | 483 |
|
|
2021
Q1 | $1.58M | Buy |
+54,342
| New | +$1.58M | 0.01% | 514 |
|